Market Snapshot

Study Period: | 2018 - 2026 |
Base Year: | 2021 |
CAGR: | 5.2 % |
![]() |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The major factors that are responsible for the growth of the artificial organs and bionics market includes rising incidence of road accidents, and technological advancements in the artificial organ and bionics market.
Another primary factor is the scarcity of donor organs. The lack of availability of potential organs to transplant has been a major issue. The demand for organ donors is ever increasing, and is very high compared to the actual supply. According to European Directorate for the Quality of Medicines & HealthCare (EDQM), In 2017, around 3,245 individuals active on the organ donor list in France were waiting for a liver and around 874 people were waiting for a heart. The number of patients waiting for a kidney, liver or lung transplant has also increased across the years. This has been a major boost for the artificial organ bionics market, as the patients cannot afford to wait in queue since the stakes are very high. Bionics and artificial organs are able to cater to the needs of those in need of organ transplantations and replacements. They can replicate the function of damaged organs.
However, the others factors, such as high cost of procedure is expected to impede the market growth.
Scope of the report
As per the scope of the report, Artificial organs are mechanical devices that can temporarily or permanently substitute for a body organ. The Artificial Organs are made by a human and are implemented in human bodies with living tissue. Bionics refers to replacement or improvement of body parts by mechanical kinds.
By Type | ||||||
| ||||||
|
Key Market Trends
Artificial Kidney Segment is Expected to Show Better Growth in the Forecast Years
Based on Artificial Organ, the market is segmented into Artificial Heart, Artificial Kidney, Artificial Lungs, Cochlear Implants and Other Organ Types. The high growth of the segment is attributed to the large patient population and the rising number of transplant surgeries. According to European Directorate for the Quality of Medicines & HealthCare (EDQM), in 2017, there were approximately 18.8 thousand active patients on the organ transplant waiting list for a kidney transplant in France. Thus, rising chronic diseases, organ failures and initiatives by government and various organizations are expected to drive the market in the forecast period.

To understand key trends, Download Sample Report
Competitive Landscape
The majority of the artificial organs and bionics is being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. This has helped the market grow.
Major Players

Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Incidence of Road Accidents
-
4.2.2 Scarcity of Donor Organs
-
4.2.3 Technological Advancements in the Artificial Organ and Bionics
-
-
4.3 Market Restraints
-
4.3.1 Expensive Procedures
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 Artificial Organ
-
5.1.1.1 Artificial Heart
-
5.1.1.2 Artificial Kidney
-
5.1.1.3 Cochlear Implants
-
5.1.1.4 Other Organ Types
-
-
5.1.2 Bionics
-
5.1.2.1 Vision Bionics
-
5.1.2.2 Ear Bionics
-
5.1.2.3 Orthopedic Bionic
-
5.1.2.4 Cardiac Bionics
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abiomed Inc
-
6.1.2 Asahi Kasei Medical Co., Ltd
-
6.1.3 Boston Scientific Corporation
-
6.1.4 LivaNova PLC
-
6.1.5 Esko Bionics
-
6.1.6 Ossur
-
6.1.7 Getinge AB
-
6.1.8 Medtronic PLC
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The France Artificial Organs and Bionics Market market is studied from 2018 - 2026.
What is the growth rate of France Artificial Organs and Bionics Market?
The France Artificial Organs and Bionics Market is growing at a CAGR of 5.2% over the next 5 years.
Who are the key players in France Artificial Organs and Bionics Market?
Boston Scientific Corporation, Ossur, Medtronic PLC, Getinge AB, Abiomed Inc are the major companies operating in France Artificial Organs and Bionics Market.